Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DK126070,DK072517,UL1 TR001872
University of California Drug Discovery Consortium
Grant: n/a
Cystic Fibrosis Foundation
Grant: CIL21G0,VERKMA18G0
NIDDK NIH HHS
Grant: R01 DK126070
NIDDK NIH HHS
Grant: P30 DK072517
National Institutes of Health
Grant: 5P30DK072517-02
CORE--CLINICAL RESOURCES
National Institutes of Health
Grant: 5R01DK126070-05
SLC26A3 (DRA) Inhibitors for Treatment of Hyperoxaluria and Nephrolithiasis
National Institutes of Health
Grant: 5UL1TR001872-02
Clinical and Translational Science Institute
FWCI
2.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals